Novogene Europe Relocates its Sequencing Centre to Cambridge Science Park
CAMBRIDGE, UK, Oct 17, 2019 – Novogene Europe has upgraded and relocated its first European Sequencing Centre to TusPark UK’s new Bio-Innovation Centre in the Cambridge Science Park. The grand opening ceremony of Novogene’s new facility was held at 2 pm, 11th October 2019.
The move to the Bio-Innovation Centre has enabled Novogene’s Cambridge Sequencing Centre to expand its operation and continue to provide unsurpassed turnaround times and guaranteed data quality. With a professional team recruited from all over the world, the Centre offers leading-edge Next Generation Sequencing (NGS) services and solutions for all types of projects. The lab is now equipped with a variety of platforms, including an automatic system for library preparation, multiple NovaSeq 6000s and High Performance Computing Clusters. Novogene Cambridge Sequencing Centre is now capable of performing more than 280,000 human WGS analysis per year.
Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise, and more advanced sequencing capacity in the world. The Novogene Europe subsidiary was established in 2014 to address the European market for NGS and expand Novogene’s business in Europe. Novogene Europe now provides leading edge services and solutions to customers in over 30 countries in Europe.
Novogene’s comprehensive service offering at its Cambridge Sequencing Centre includes human genome sequencing, plant and animal genome sequencing, transcriptome sequencing, metagenome sequencing, and lanes sequencing. Additional services are planned for the near future enabling Novogene Europe to provide even more optimized solutions for clients based on their research goals.
Ms. Tingting Zhou, the general manager of Novogene Europe, said, “The relocation of Novogene Cambridge Sequencing Centre helps us to improve our services, which is a significant development milestone of Novogene Europe. This means that we can deliver higher levels of NGS services and help our clients to solve the practical problems in their research. Our customers encouraged us to expand our services as we have always been trying to maximize the benefits for our customers. I also believe that our Cambridge Sequencing Centre will continue to thrive.”
“We are delighted to welcome Novogene to the Bio-Innovation Centre,” said Dr. David Chaplin, TusPark UK’s General Manager of the Bio-Innovation Centre. “Emerging technologies like NGS play critical roles in human health, environmental protection, plant and animal breeding and microbial remediation. The relocation of Novogene Cambridge Sequencing Centre is a fantastic new addition to the Cambridge Science Park. It’s our pleasure to establish a long-term relationship and grow together with Novogene.”
About Novogene Europe
Novogene Europe, established in 2014, is a Subsidiary of Novogene. It makes significant contributions to advancing human heath, agriculture, and environmental protection. Over 300 scientific research institutes and biotechnology companies in Europe rely on the powerful technologies and services of Novogene Europe. With leading-edge platforms, well developed bioinformatics pipelines, extensive experience in NGS, and the support from skilled employees, Novogene Europe has become the most competitive NGS provider in Europe.
About Cambridge Science Park
The Cambridge Science Park was established in 1970 by Trinity College – the largest of the colleges of the University of Cambridge. Trinity owns the freehold of the Cambridge Science Park which comprises 1.7 million sq ft of high technology and laboratory buildings set in 152 acres of mature parkland. Today, the Park is home to 7000 people at over 130 companies ranging from exciting start-ups to some of the world’s leading technology businesses.
Ms. Tingting Zhou
Dr. Yan Wang